Company news
Ibio, Inc. (NASDAQ:IBIO) news
Ibio, Inc. news releases on 6ix. Latest, Apr 27, 2020: iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
Press releases — page 3
iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
April 26, 2020
iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute
April 8, 2020
iBio Announces Advancement of COVID-19 Vaccine Program
March 25, 2020
iBio Joins the Alliance for Biosecurity
March 19, 2020
iBio Announces Development of Proprietary COVID-19 Vaccine Candidates
March 17, 2020
iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO
March 11, 2020
iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
March 1, 2020
iBio, Inc. Announces Postponement of Annual Meeting
February 5, 2020
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
January 15, 2020
iBio Initiates New Litigation Against Fraunhofer
January 5, 2020
iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing
December 22, 2019
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
December 12, 2019
iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production
December 9, 2019
iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative
December 2, 2019